NF-kappaB: linking inflammation and immunity to cancer development and progression
- PMID: 16175180
- DOI: 10.1038/nri1703
NF-kappaB: linking inflammation and immunity to cancer development and progression
Abstract
There has been much effort recently to probe the long-recognized relationship between the pathological processes of infection, inflammation and cancer. For example, epidemiological studies have shown that approximately 15% of human deaths from cancer are associated with chronic viral or bacterial infections. This Review focuses on the molecular mechanisms that connect infection, inflammation and cancer, and it puts forward the hypothesis that activation of nuclear factor-kappaB (NF-kappaB) by the classical, IKK-beta (inhibitor-of-NF-kappaB kinase-beta)-dependent pathway is a crucial mediator of inflammation-induced tumour growth and progression, as well as an important modulator of tumour surveillance and rejection.
Similar articles
-
NF-κB, inflammation, immunity and cancer: coming of age.Nat Rev Immunol. 2018 May;18(5):309-324. doi: 10.1038/nri.2017.142. Epub 2018 Jan 22. Nat Rev Immunol. 2018. PMID: 29379212 Review.
-
Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.Biochim Biophys Acta. 2014 Feb;1842(2):175-85. doi: 10.1016/j.bbadis.2013.11.001. Epub 2013 Nov 8. Biochim Biophys Acta. 2014. PMID: 24215713
-
New regulators of NF-kappaB in inflammation.Nat Rev Immunol. 2008 Nov;8(11):837-48. doi: 10.1038/nri2423. Nat Rev Immunol. 2008. PMID: 18927578 Review.
-
The non-canonical NF-κB pathway in immunity and inflammation.Nat Rev Immunol. 2017 Sep;17(9):545-558. doi: 10.1038/nri.2017.52. Epub 2017 Jun 5. Nat Rev Immunol. 2017. PMID: 28580957 Free PMC article. Review.
-
NF-κB cellular and molecular regulatory mechanisms and pathways: therapeutic pattern or pseudoregulation?Cell Immunol. 2011;271(1):5-14. doi: 10.1016/j.cellimm.2011.06.021. Epub 2011 Jun 26. Cell Immunol. 2011. PMID: 21777910 Review.
Cited by
-
NF-κB signaling pathway in tumor microenvironment.Front Immunol. 2024 Oct 18;15:1476030. doi: 10.3389/fimmu.2024.1476030. eCollection 2024. Front Immunol. 2024. PMID: 39493763 Free PMC article. Review.
-
Could gastrointestinal tumor-initiating cells originate from cell-cell fusion in vivo?World J Gastrointest Oncol. 2021 Feb 15;13(2):92-108. doi: 10.4251/wjgo.v13.i2.92. World J Gastrointest Oncol. 2021. PMID: 33643526 Free PMC article. Review.
-
Profiling microRNAs in lung tissue from pigs infected with Actinobacillus pleuropneumoniae.BMC Genomics. 2012 Sep 6;13:459. doi: 10.1186/1471-2164-13-459. BMC Genomics. 2012. PMID: 22953717 Free PMC article.
-
The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation.Cell Mol Immunol. 2024 Jan;21(1):60-79. doi: 10.1038/s41423-023-01112-y. Epub 2023 Dec 7. Cell Mol Immunol. 2024. PMID: 38062129 Free PMC article.
-
miRNAs: possible regulators of toll like receptors and inflammatory tumor microenvironment in colorectal cancer.BMC Cancer. 2024 Jul 10;24(1):824. doi: 10.1186/s12885-024-12417-0. BMC Cancer. 2024. PMID: 38987740 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources